Hence, selective ROCK-2 inhibition by KD025, in contrast to a nonselective ROCK inhibition strategy, has a potent capacity to antagonise the actions of rt-PA and plasmin on the BBB under stroke-like conditions. The gene discussed is PLG; the disease is Stroke.